ArticleOncotarget2018

Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer.

Qi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.